EP3206491
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.10.2015EP published:
27.11.2019EP application number:
15851308.5
EPO information:
European Patent Register
Max expiry date:
15.10.2035
Title:
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
Timeline
Today
16.10.2015EP application
27.11.2019EP Publication
Owner
Name:
Salix Pharmaceuticals, Inc.Address:
400 Somerset Corporate Boulevard, 08807, Bridgewater, NJ, US
Name:
The University of ChicagoAddress:
5801 South Ellis Avenue, 60637, Chicago, IL, US
Inventor
Name:
MOSS, JonathanAddress:
Chicago, IL, US
Name:
JOHNSON, Lorin K.Address:
Los Altos Hills, California, US
Priority
Number:
201462065550 PDate:
17.10.2014Country:
US
Number:
201562140876 PDate:
31.3.2015Country:
US
Number:
201562222746 PDate:
23.9.2015Country:
US
Classification
Categories:
A61K 45/06, A61P 35/00